Reviewed,
UniProtKB/Swiss-Prot P20963 (CD3Z_HUMAN)
Last modified
January 19, 2010.
Version 114.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: T-cell surface glycoprotein CD3 zeta chain Alternative name(s): T-cell receptor T3 zeta chain CD_antigen=CD247 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 164 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Probable role in assembly and expression of the TCR complex as well as signal transduction upon antigen triggering. |
| Subunit structure | The TCR/CD3 complex of T-lymphocytes consists of either a TCR alpha/beta or TCR gamma/delta heterodimer coexpressed at the cell surface with the invariant subunits of CD3 labeled gamma, delta, epsilon, zeta, and eta. CD3-zeta forms either homodimers or heterodimers with CD3-eta. Interacts with SLA and SLA2. Interacts with DOCK2 and TRAT1. Interacts with HIV-1 Nef protein. Interacts with SHB. Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 |
| Subcellular location | |
| Domain | The ITAM domains mediate interaction with SHB. |
| Post-translational modification | Phosphorylated on Tyr residues after T-cell receptor triggering By similarity. Ref.12 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 |
| Involvement in disease | Defects in CD247 are a cause of primary T-cell immunodeficiency [MIM:610163]. Affected individuals suffer of recurrent infections. Patients T-cell counts are very low and B-cell counts are normal. Ref.19 |
| Sequence similarities | Belongs to the CD3Z/FCER1G family. Contains 3 ITAM domains. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Host-virus interaction |
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing |
| Domain | Repeat Signal Transmembrane |
| Molecular function | Receptor |
| PTM | Disulfide bond Phosphoprotein |
| Technical term | 3D-structure Complete proteome |
| Gene Ontology (GO) | |
| Biological process | cell surface receptor linked signal transduction Inferred from electronic annotation. Source: InterPro interspecies interaction between organismsInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | T cell receptor complex Inferred from direct assay. Source: MGI cytoplasm Ref.10Inferred from direct assay. Source: MGI integral to membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | protein homodimerization activity Non-traceable author statement. Source: UniProtKB transmembrane receptor activityInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| itself | 2 | EBI-1165705,EBI-1165705 | ||
| LCK | P06239 | 1 | EBI-1165705,EBI-1348 | |
| PTPN22 | Q9Y2R2 | 2 | EBI-1165705,EBI-1211241 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P20963-1) Also known as: CD-3-zeta; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P20963-2) Also known as: CD-3-eta; The sequence of this isoform is not available. | ||||||
| Isoform 3 (identifier: P20963-3) The sequence of this isoform differs from the canonical sequence as follows: 101-101: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 21 | 21 | |||||||||
| Chain | 22 – 164 | 143 | T-cell surface glycoprotein CD3 zeta chain | PRO_0000016493 | |||||||
Regions | |||||||||||
| Topological domain | 22 – 30 | 9 | Extracellular Potential | ||||||||
| Transmembrane | 31 – 51 | 21 | Potential | ||||||||
| Topological domain | 52 – 164 | 113 | Cytoplasmic Potential | ||||||||
| Domain | 61 – 89 | 29 | ITAM 1 | ||||||||
| Domain | 100 – 128 | 29 | ITAM 2 | ||||||||
| Domain | 131 – 159 | 29 | ITAM 3 | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 58 | 1 | Phosphoserine Ref.13 | ||||||||
| Modified residue | 64 | 1 | Phosphotyrosine Ref.13 Ref.14 Ref.15 Ref.17 | ||||||||
| Modified residue | 72 | 1 | Phosphotyrosine Ref.14 Ref.15 Ref.17 | ||||||||
| Modified residue | 83 | 1 | Phosphotyrosine Ref.12 Ref.14 Ref.15 Ref.17 | ||||||||
| Modified residue | 111 | 1 | Phosphotyrosine Ref.12 Ref.14 Ref.15 Ref.16 Ref.17 | ||||||||
| Modified residue | 123 | 1 | Phosphotyrosine Ref.12 Ref.15 Ref.17 | ||||||||
| Modified residue | 142 | 1 | Phosphotyrosine Ref.12 Ref.14 Ref.15 Ref.17 | ||||||||
| Modified residue | 153 | 1 | Phosphotyrosine Ref.15 Ref.17 | ||||||||
| Disulfide bond | 32 | Interchain Potential | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 101 | 1 | Missing in isoform 3. | VSP_036459 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 60 – 61 | 2 | DA → EP in AAA60394. Ref.1 | ||||||||
Secondary structure | |||||||||||
Helix Strand Turn | |||||||||||
| Helix | 31 – 54 | 24 | |||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and chromosomal localization of the human T-cell receptor zeta chain: distinction from the molecular CD3 complex." Weissman A.M., Hou D., Orloff D.G., Modi W.S., Seuanez H., O'Brien S.J., Klausner R.D. Proc. Natl. Acad. Sci. U.S.A. 85:9709-9713(1988) [PubMed: 2974162] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Skeletal muscle. |
| [3] | NIEHS SNPs program Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [4] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Pancreas. |
| [7] | "Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins." Welsh M., Songyang Z., Frantz J.D., Trueb T., Reedquist K.A., Karlsson T., Miyazaki M., Cantley L.C., Band H., Shoelson S.E. Oncogene 16:891-901(1998) [PubMed: 9484780] [Abstract] Cited for: INTERACTION WITH SHB. |
| [8] | "Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain." Xu X.-N., Laffert B., Screaton G.R., Kraft M., Wolf D., Kolanus W., Mongkolsapay J., McMichael A.J., Baur A.S. J. Exp. Med. 189:1489-1496(1999) [PubMed: 10224289] [Abstract] Cited for: INTERACTION WITH HIV-1 NEF. |
| [9] | "SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling." Tang J., Sawasdikosol S., Chang J.-H., Burakoff S.J. Proc. Natl. Acad. Sci. U.S.A. 96:9775-9780(1999) [PubMed: 10449770] [Abstract] Cited for: INTERACTION WITH SLA. |
| [10] | "The transmembrane adaptor protein TRIM regulates T-cell receptor (TCR) expression and TCR-mediated signaling via an association with the TCR zeta chain." Kirchgessner H., Dietrich J., Scherer J., Isomaeki P., Korinek V., Hilgert I., Bruyns E., Leo A., Cope A.P., Schraven B. J. Exp. Med. 193:1269-1284(2001) [PubMed: 11390434] [Abstract] Cited for: INTERACTION WITH TRAT1. |
| [11] | "DOCK2 mediates T cell receptor-induced activation of Rac2 and IL-2 transcription." Nishihara H., Maeda M., Tsuda M., Makino Y., Sawa H., Nagashima K., Tanaka S. Biochem. Biophys. Res. Commun. 296:716-720(2002) [PubMed: 12176041] [Abstract] Cited for: INTERACTION WITH DOCK2. |
| [12] | "Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry." Salomon A.R., Ficarro S.B., Brill L.M., Brinker A., Phung Q.T., Ericson C., Sauer K., Brock A., Horn D.M., Schultz P.G., Peters E.C. Proc. Natl. Acad. Sci. U.S.A. 100:443-448(2003) [PubMed: 12522270] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-83; TYR-111; TYR-123 AND TYR-142, MASS SPECTROMETRY. |
| [13] | "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry." Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C. Anal. Chem. 76:2763-2772(2004) [PubMed: 15144186] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND TYR-64, MASS SPECTROMETRY. Tissue: T-cell. |
| [14] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-64; TYR-72; TYR-83; TYR-111 AND TYR-142, MASS SPECTROMETRY. |
| [15] | "Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry." Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J., Bodenmiller B., Watts J.D., Hood L., Aebersold R. Nat. Methods 2:591-598(2005) [PubMed: 16094384] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-64; TYR-72; TYR-83; TYR-111; TYR-123; TYR-142 AND TYR-153, MASS SPECTROMETRY. Tissue: T-cell. |
| [16] | "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. Comb M.J.Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-111, MASS SPECTROMETRY. |
| [17] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-64; TYR-72; TYR-83; TYR-111; TYR-123; TYR-142 AND TYR-153, MASS SPECTROMETRY. Tissue: T-cell. |
| [18] | "Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms." Waksman G., Shoelson S.E., Pant N., Cowburn D., Kuriyan J. Cell 72:779-790(1993) [PubMed: 7680960] [Abstract] Cited for: STRUCTURE BY NMR OF 136-149. |
| [19] | "Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency." Rieux-Laucat F., Hivroz C., Lim A., Mateo V., Pellier I., Selz F., Fischer A., Le Deist F. N. Engl. J. Med. 354:1913-1921(2006) [PubMed: 16672702] [Abstract] Cited for: INVOLVEMENT IN PRIMARY T-CELL IMMUNODEFICIENCY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | J04132 mRNA. Translation: AAA60394.1. AK313946 mRNA. Translation: BAG36664.1. DQ072717 Genomic DNA. Translation: AAY57330.1. AL359962, AL031733 Genomic DNA. Translation: CAH69974.1. AL359962, AL031733 Genomic DNA. Translation: CAH69975.1. AL031733, AL359962 Genomic DNA. Translation: CAI21380.1. AL031733, AL359962 Genomic DNA. Translation: CAI21381.1. CH471067 Genomic DNA. Translation: EAW90792.1. BC025703 mRNA. Translation: AAH25703.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00218634. IPI00375504. | ||||||||||||||||||||||||||||||
| PIR | A31768. | ||||||||||||||||||||||||||||||
| RefSeq | NP_000725.1. NP_932170.1. | ||||||||||||||||||||||||||||||
| UniGene | Hs.156445 | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| DisProt | DP00200. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| IntAct | P20963. 3 interactions. | ||||||||||||||||||||||||||||||
| STRING | P20963. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P20963. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PRIDE | P20963. | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENST00000362089; ENSP00000354782; ENSG00000198821; Homo sapiens. [Genome view] | ||||||||||||||||||||||||||||||
| GeneID | 919. | ||||||||||||||||||||||||||||||
| KEGG | hsa:919. | ||||||||||||||||||||||||||||||
| UCSC | uc001gei.2. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 919. | ||||||||||||||||||||||||||||||
| GeneCards | GC01M165666. | ||||||||||||||||||||||||||||||
| H-InvDB | HIX0001296. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:1677. CD247. | ||||||||||||||||||||||||||||||
| HPA | CAB004651. HPA008750. | ||||||||||||||||||||||||||||||
| MIM | 186780. gene. 610163. phenotype. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | prNOG20849. | ||||||||||||||||||||||||||||||
| HOVERGEN | P20963. | ||||||||||||||||||||||||||||||
| OMA | HMQALPP. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG90KBJ4. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | cd8tcrdownstreampathway. Downstream signaling in naive CD8+ T cells. hivnefpathway. HIV-1 Nef: Negative effector of Fas and TNF-alpha. il12_stat4pathway. IL12 signaling mediated by STAT4. il12_2pathway. IL12-mediated signaling events. tcrpathway. TCR signaling in naive CD4+ T cells. cd8tcrpathway. TCR signaling in naive CD8+ T cells. | ||||||||||||||||||||||||||||||
| Reactome | REACT_6185. HIV Infection. REACT_6900. Signaling in Immune system. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P20963. | ||||||||||||||||||||||||||||||
| Bgee | P20963. | ||||||||||||||||||||||||||||||
| CleanEx | HS_CD247. | ||||||||||||||||||||||||||||||
| Genevestigator | P20963. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000198821. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR003110. Phos_immunorcpt_sig_ITAM. [Graphical view] | ||||||||||||||||||||||||||||||
| Pfam | PF02189. ITAM. 3 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| SMART | SM00077. ITAM. 3 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS51055. ITAM_1. 3 hits. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||||||||
| NextBio | 3800. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | CD3Z_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P20963 Secondary accession number(s): B1AK49, Q5VX13, Q8TAX4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


